Author: Gross, Michael
Title: The renaissance of RNA therapies Cord-id: 1rkeq9xh Document date: 2021_6_21
ID: 1rkeq9xh
Snippet: The success of the rapid development of mRNA vaccines against COVID-19 will enable the mRNA companies to bring their other products to market as well, many of which had been simmering in clinical trials for years before the pandemic. The most promising targets for new mRNA therapies include several types of cancer, as well as liver disease and multiple sclerosis. Michael Gross reports.
Document: The success of the rapid development of mRNA vaccines against COVID-19 will enable the mRNA companies to bring their other products to market as well, many of which had been simmering in clinical trials for years before the pandemic. The most promising targets for new mRNA therapies include several types of cancer, as well as liver disease and multiple sclerosis. Michael Gross reports.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date